Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Phase II Study of Denosumab (IND #127430; NSC# 744010); a RANK Ligand Antibody; for Recurrent or Refractory OsteosarcomaCIRB: Pediatric CIRBLead Group: COGStatus: ActiveReview Status: Available to Open
